Hippocratic AI nabs $17M from Nvidia
Hippocratic AI, a company developing a generative artificial intelligence model for healthcare, has secured $17 million in an undisclosed funding round.
NVentures, the venture capital arm of technology company Nvidia, was an investor in the round along with venture capital firm Greycroft.
Related: Top digital health funding: Wellstar, UnitedHealth invest in AI
Hippocratic is developing a generative AI model that aims to help providers complete non-diagnostic and patient-facing tasks. Large venture capital firms General Catalyst and Andreessen Horowitz have already backed Hippocratic AI, which has raised $137 million including this round.
Hippocratic AI said in a press release it was using Nvidia's chipmaker technology to scale its platform. Along with Hippocratic AI, Nvidia has signed agreements to power the AI models of digital health companies GE HealthCare, Nuance and Abridge, along with working on drug discovery and development for a host of pharmaceutical companies, including Amgen.
Centivo gets $75M from Cone Health venture arm, others
Insurance startup Centivo has raised $75 million in equity and debt financing. Read more.
Radiology AI company raises $65M for U.S. expansion
Qure.ai, a radiology-focused AI company, has closed a $65 million Series D funding round.
Venture capital firm Lightspeed Venture Partners and investment firm 360 One Asset co-led the round. Other investors included a fund associated pharmaceutical company Merck and early-stage investment firm Kae Capital.
The company has developed AI tools focused on public health, tuberculosis, lung cancer and stroke care to help clinicians make diagnoses. Qure.ai said in a release it would use the funds to expand the company's foundational AI models and to acquire other medical technology companies.
Mendaera closes $73M Series B funding round
Mendaera, a healthcare robotics company, closed of a $73 million Series B funding round.
Venture capital firm Threshold Ventures led the round. Venture firm Lux Capital and investment firm PFM Health Sciences also participated.
The company is developing a handheld robotic platform for providers that uses AI, real-time imaging and virtual connectivity. Mendaera said it will use the funding to scale its robotics and AI technology.
